PRF Technologies Ltd. (PRFX) Form 6-K — Sep 3, 2026
PRF Technologies Ltd., formerly PainReform (ticker PRFX), reported revenues of just $14 thousand and a net loss of $2.94 million for the six months ended June 30, 2026, wider than the $2.32 million loss a year earlier. Loss per share improved to $2.25 from $5.63 only because of a much larger share count. The company ended the half with $8.5 million of cash and equivalents, or $11.6 million including restricted cash and short-term deposits, after fully drawing a $10.0 million Standby Equity Purchase Agreement with Yorkville in May 2026. A second $15.0 million SEPA signed in June 2026 was undrawn at quarter-end, and 437,000 additional shares were sold for $447 thousand after the period closed.
Key figures
- Revenue
- 14000
- Total Assets
- 19090000
- Cash Position
- 8526000
- Shares Outstanding
- 3041830
- Working capital
- 9538000
- Revenue prior year
- 0
- Accumulated deficit
- 64086000
- Reverse split ratio
- 1-for-5 (effected February 6, 2026)
- Short term deposits
- 3009000
- Warrants outstanding
- 2894259
- Post period sepa proceeds
- 447000
- Sepa drawn gross may 2026
- 10000000
- Sepa shares issued may 2026
- 2152798
- Post period sepa shares sold
- 437000
- Shares outstanding dec 31 2025
- 830613
- Full dilution additional shares
- 448797
- Sepa undrawn commitment june 2026
- 15000000
- Total cash incl restricted and deposits
- 11562000
- Sepa commitment fees in finance expenses
- 371000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.